Nureca Limited approached NPCS with the objective of evaluating a large-scale manufacturing project that could offer long-term growth, recurring market demand, and sustainable business potential. With a strong interest in entering the healthcare manufacturing sector, the company sought expert guidance to identify a commercially attractive and technically feasible opportunity.
After conducting an extensive techno-economic evaluation, NPCS recommended the establishment of an IV Cannulas Manufacturing Unit. The recommendation was based on strong market fundamentals, rising demand for medical disposables, expanding healthcare infrastructure, and the growing need for high-quality, single-use medical products across hospitals, clinics, diagnostic centres, and public healthcare institutions.
As part of the engagement, NPCS carried out a comprehensive study covering market demand, manufacturing feasibility, raw material sourcing, production requirements, financial viability, and implementation planning. The assessment also examined investment requirements, profitability potential, operational scalability, and key regulatory considerations associated with medical device manufacturing.
The study highlighted the advantages of entering a healthcare segment driven by recurring institutional demand and supported by increasing investments in healthcare services across India and international markets. The project was found to be commercially viable, technically sound, and well aligned with the client's long-term investment goals.
The detailed analysis provided Nureca Limited with a clear understanding of the manufacturing process, infrastructure requirements, financial outlook, and implementation pathway. Based on the findings, the company decided to proceed with project development and move forward with the next stages of implementation.